Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients

NCT06703593 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Female

Interventions

DRUG: Alpha lipoic acid

Sponsor

British University In Egypt

Collaborators

[object Object]